Diagnosis Sheet
Neurodevelopmental Disorders DSM-5-TR 307.22 | ICD-10-CM F95.1
Persistent (Chronic) Motor or Vocal Tic Disorder
Single or multiple motor tics or vocal tics, but never both, persisting more than one year since first tic onset before age 18.
Prevalence~1-2% of children
Typical onsetAges 4-6; worst at 10-12
Sex ratio~3-4:1 male:female
CourseWaxes/wanes; most improve by 18
Clinical picture
- Sudden, rapid, recurrent, nonrhythmic movements or vocalizations that wax and wane in type, frequency, and anatomic location.
- Simple motor tics include eye blinking, grimacing, head jerks, and shoulder shrugs; vocal tics include sniffing, throat clearing, and grunting.
- A premonitory urge, described as building tension or an itch, precedes the tic and is transiently relieved by performing it.
- Tics are suppressible for minutes to hours at the cost of mounting discomfort, then rebound in a burst once attention shifts.
- Stress, fatigue, excitement, and talking about tics increase frequency; absorbing focused activity usually reduces them.
- Impairment more often stems from comorbid ADHD and OCD, pain from forceful tics, and teasing than from tics themselves.
Criteria snapshot
- One or more motor tics or vocal tics have been present, but never both motor and vocal tics across the illness course.
- Tics may wax and wane in frequency but have persisted for more than one year since the first tic appeared.
- Onset must occur before age 18; later onset requires evaluation for secondary or functional tic-like behaviors instead.
- Not attributable to a substance such as stimulants or cocaine, or a medical condition such as Huntington disease or postviral encephalitis.
- Criteria for Tourette's disorder have never been met; specify with motor tics only or with vocal tics only.
Neurobiology
- Cortico-striato-thalamo-cortical dysfunction with failure of striatal inhibition allows unwanted motor programs to release.
- Excess dopaminergic tone in the striatum underlies the benefit of dopamine receptor blockers and VMAT2 inhibitors.
- Reduced GABAergic interneuron density in caudate and putamen is a replicated postmortem finding in severe tic disorders.
- Heritability approximates 0.6-0.8; rare variants in NRXN1, CNTN6, and CELSR3 have been implicated in tic disorders.
- Sensorimotor cortical thinning and impaired short-interval intracortical inhibition on TMS index the motor control deficit.
- The premonitory urge maps onto insula and supplementary motor area activity, framing tics as urge-driven rather than purely involuntary.
Psychology
- Tics are negatively reinforced: performing the tic terminates the aversive premonitory urge, strengthening the habit loop.
- Contextual cues become conditioned triggers, explaining why tics cluster in particular settings and with particular people.
- Habit reversal exploits that learning by pairing urge awareness with a physically incompatible competing response.
- Attempted suppression demanded by parents and teachers raises anxiety and tic burden, and reprimand is counterproductive.
- Self-consciousness and anticipated ridicule drive social avoidance that outlasts objectively measured tic severity.
Differential & comorbidity
- Differentiate from Tourette's disorder, requiring multiple motor plus at least one vocal tic, and provisional tic disorder under one year.
- Exclude stereotypies, myoclonus, chorea, dystonia, seizures, and compulsions; tics are suppressible and urge-preceded.
- Rapid adolescent onset of complex tic-like behaviors, often in girls after social media exposure, suggests a functional disorder.
- ADHD co-occurs in 50-60% and OCD in 30-50%; both typically cause more impairment than the tics themselves do.
- Screen for anxiety, mood disorder, rage attacks, learning disorder, and self-injurious tics at every clinical visit.
Pharmacologic treatment
- Treat only when tics cause pain, impairment, or distress; watchful waiting plus education is appropriate for mild tics.
- Alpha-2 agonists are first-line: guanfacine ER 1-4 mg/day or clonidine 0.05-0.4 mg/day, especially with comorbid ADHD.
- Antipsychotics are most effective: aripiprazole 2-20 mg/day, risperidone, haloperidol, or pimozide, with metabolic and EPS monitoring.
- VMAT2 inhibitors and topiramate are alternatives; botulinum toxin targets a single focal disabling motor or vocal tic.
- Stimulants for comorbid ADHD do not meaningfully worsen tics in most children and should not be withheld reflexively.
Psychotherapy
- CBIT is first-line behavioral treatment: 8 sessions over 10 weeks combining habit reversal with function-based interventions.
- The pivotal randomized trial found roughly 53% much or very much improved with CBIT versus 19% with supportive therapy.
- Exposure and response prevention for tics trains urge tolerance without performing the tic and rivals habit reversal training.
- Treating comorbid OCD and anxiety with ERP or CBT often produces more functional gain than reducing tic counts.
- Psychoeducation for family and school reframes tics as involuntary, immediately lowering blame and suppression demands.
Adjunct options
- Rate severity with the YGTSS and premonitory urge with the PUTS to track response objectively across visits.
- School plans allow a tic break, discreet exits, testing in a separate room, and scribing when tics impair written work.
- Sleep regulation, exercise, and stress reduction modestly lower tic burden and improve comorbid ADHD and anxiety.
- Deep brain stimulation of thalamic or pallidal targets is reserved for severe, refractory, malignant tic disorders in adults.
- Connect families to the Tourette Association of America for advocacy, school toolkits, and peer support networks.
Clinical pearls
- If tics are both motor and vocal, the diagnosis is Tourette's, not persistent tic disorder.
- Treat the ADHD and OCD first; they usually cause more impairment than the tics.
- Stimulants do not cause tics; withholding them costs the child more than it saves.
References
- American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). https://doi.org/10.1176/appi.books.9780890425787
- Murphy, T. K., Lewin, A. B., Storch, E. A., & Stock, S. (2013). Practice parameter for the assessment and treatment of children and adolescents with tic disorders. Journal of the American Academy of Child & Adolescent Psychiatry, 52(12), 1341-1359. https://doi.org/10.1016/j.jaac.2013.09.015
- National Institute of Neurological Disorders and Stroke. (n.d.). Tourette syndrome. National Institutes of Health. https://www.ninds.nih.gov/health-information/disorders/tourette-syndrome
- Piacentini, J., Woods, D. W., Scahill, L., Wilhelm, S., Peterson, A. L., Chang, S., Ginsburg, G. S., Deckersbach, T., Dziura, J., Levi-Pearl, S., & Walkup, J. T. (2010). Behavior therapy for children with Tourette disorder: A randomized controlled trial. JAMA, 303(19), 1929-1937. https://doi.org/10.1001/jama.2010.607
- Pringsheim, T., Okun, M. S., Muller-Vahl, K., Martino, D., Jankovic, J., Cavanna, A. E., Woods, D. W., Robinson, M., Jarvie, E., Roessner, V., Oskoui, M., Holler-Managan, Y., & Piacentini, J. (2019). Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology, 92(19), 896-906. https://doi.org/10.1212/WNL.0000000000007466
- Sadock, B. J., Sadock, V. A., & Ruiz, P. (2021). Kaplan & Sadock's synopsis of psychiatry (12th ed.). Wolters Kluwer.